Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization - PubMed (original) (raw)
. 2004 Sep 23;351(13):1296-305.
doi: 10.1056/NEJMoa041031.
Affiliations
- PMID: 15385656
- DOI: 10.1056/NEJMoa041031
Free article
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Alan S Go et al. N Engl J Med. 2004.
Free article
Erratum in
- N Engl J Med. 2008;18(4):4
Abstract
Background: End-stage renal disease substantially increases the risks of death, cardiovascular disease, and use of specialized health care, but the effects of less severe kidney dysfunction on these outcomes are less well defined.
Methods: We estimated the longitudinal glomerular filtration rate (GFR) among 1,120,295 adults within a large, integrated system of health care delivery in whom serum creatinine had been measured between 1996 and 2000 and who had not undergone dialysis or kidney transplantation. We examined the multivariable association between the estimated GFR and the risks of death, cardiovascular events, and hospitalization.
Results: The median follow-up was 2.84 years, the mean age was 52 years, and 55 percent of the group were women. After adjustment, the risk of death increased as the GFR decreased below 60 ml per minute per 1.73 m2 of body-surface area: the adjusted hazard ratio for death was 1.2 with an estimated GFR of 45 to 59 ml per minute per 1.73 m2 (95 percent confidence interval, 1.1 to 1.2), 1.8 with an estimated GFR of 30 to 44 ml per minute per 1.73 m2 (95 percent confidence interval, 1.7 to 1.9), 3.2 with an estimated GFR of 15 to 29 ml per minute per 1.73 m2 (95 percent confidence interval, 3.1 to 3.4), and 5.9 with an estimated GFR of less than 15 ml per minute per 1.73 m2 (95 percent confidence interval, 5.4 to 6.5). The adjusted hazard ratio for cardiovascular events also increased inversely with the estimated GFR: 1.4 (95 percent confidence interval, 1.4 to 1.5), 2.0 (95 percent confidence interval, 1.9 to 2.1), 2.8 (95 percent confidence interval, 2.6 to 2.9), and 3.4 (95 percent confidence interval, 3.1 to 3.8), respectively. The adjusted risk of hospitalization with a reduced estimated GFR followed a similar pattern.
Conclusions: An independent, graded association was observed between a reduced estimated GFR and the risk of death, cardiovascular events, and hospitalization in a large, community-based population. These findings highlight the clinical and public health importance of chronic renal insufficiency.
Copyright 2004 Massachusetts Medical Society
Comment in
- Chronic kidney disease predicts cardiovascular disease.
Hostetter TH. Hostetter TH. N Engl J Med. 2004 Sep 23;351(13):1344-6. doi: 10.1056/NEJMe048211. N Engl J Med. 2004. PMID: 15385664 No abstract available. - Chronic renal disease and cardiovascular risk.
Risch L, Sagmeister M, Huber A. Risch L, et al. N Engl J Med. 2005 Jan 13;352(2):199-200; author reply 199-200. doi: 10.1056/NEJM200501133520217. N Engl J Med. 2005. PMID: 15647585 No abstract available. - Chronic renal disease and cardiovascular risk.
Cheng H. Cheng H. N Engl J Med. 2005 Jan 13;352(2):199-200; author reply 199-200. N Engl J Med. 2005. PMID: 15651121 No abstract available. - Improving Transitions in CKD: Failure Mode.
Yee J. Yee J. Adv Chronic Kidney Dis. 2016 Jul;23(4):211-4. doi: 10.1053/j.ackd.2016.05.001. Adv Chronic Kidney Dis. 2016. PMID: 27324671 No abstract available.
Similar articles
- Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA. Anavekar NS, et al. N Engl J Med. 2004 Sep 23;351(13):1285-95. doi: 10.1056/NEJMoa041365. N Engl J Med. 2004. PMID: 15385655 Clinical Trial. - Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Shlipak MG. Go AS, et al. Circulation. 2006 Jun 13;113(23):2713-23. doi: 10.1161/CIRCULATIONAHA.105.577577. Epub 2006 Jun 5. Circulation. 2006. PMID: 16754803 - Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population.
Astor BC, Hallan SI, Miller ER 3rd, Yeung E, Coresh J. Astor BC, et al. Am J Epidemiol. 2008 May 15;167(10):1226-34. doi: 10.1093/aje/kwn033. Epub 2008 Apr 2. Am J Epidemiol. 2008. PMID: 18385206 - [Advances in detection, evaluation and management of chronic kidney disease].
Indridason OS, Thorsteinsdóttir I, Pálsson R. Indridason OS, et al. Laeknabladid. 2007 Mar;93(3):201-7. Laeknabladid. 2007. PMID: 17341799 Review. Icelandic. - Insulin resistance underlies the elevated cardiovascular risk associated with kidney disease and glomerular hyperfiltration.
Adeva-Andany MM, Fernández-Fernández C, Carneiro-Freire N, Castro-Quintela E, Pedre-Piñeiro A, Seco-Filgueira M. Adeva-Andany MM, et al. Rev Cardiovasc Med. 2020 Mar 30;21(1):41-56. doi: 10.31083/j.rcm.2020.01.5102. Rev Cardiovasc Med. 2020. PMID: 32259903 Review.
Cited by
- Prevalence of chronic cardiovascular and metabolic diseases in Senegalese workers: a cross-sectional study, 2010.
Seck SM, Guéye S, Tamba K, Ba I. Seck SM, et al. Prev Chronic Dis. 2013;10:110339. doi: 10.5888/pcd10.110339. Prev Chronic Dis. 2013. PMID: 23286359 Free PMC article. - Cardiovascular risk assessment in children with chronic kidney disease.
Shroff R, Dégi A, Kerti A, Kis E, Cseprekál O, Tory K, Szabó AJ, Reusz GS. Shroff R, et al. Pediatr Nephrol. 2013 Jun;28(6):875-84. doi: 10.1007/s00467-012-2325-3. Epub 2012 Oct 16. Pediatr Nephrol. 2013. PMID: 23070276 Review. - Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein.
Kon V, Yang H, Fazio S. Kon V, et al. Arch Med Res. 2015 Jul;46(5):379-91. doi: 10.1016/j.arcmed.2015.05.009. Epub 2015 May 23. Arch Med Res. 2015. PMID: 26009251 Free PMC article. Review. - Non-High-Density Lipoprotein Cholesterol and Cardiovascular Outcomes in Chronic Kidney Disease: Results from KNOW-CKD Study.
Suh SH, Oh TR, Choi HS, Kim CS, Bae EH, Ma SK, Oh KH, Han SH, Kim SW; Korean Cohort Study for Outcomes in Patients with Chronic Kidney Disease (KNOW-CKD) Investigators. Suh SH, et al. Nutrients. 2022 Sep 14;14(18):3792. doi: 10.3390/nu14183792. Nutrients. 2022. PMID: 36145167 Free PMC article. - Evaluation of preprocedural statin loading on clinical outcomes in patients undergoing elective percutaneous coronary intervention.
Sinan UY, Keskin Meric B, Bursa N, Moumin G, Kaya A, Arat Ozkan A. Sinan UY, et al. Front Cardiovasc Med. 2024 Aug 20;11:1435989. doi: 10.3389/fcvm.2024.1435989. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39228664 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical